In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes

After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugs have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in the replication cycle of the novel coronavirus. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaldam, Moataz A., Yahya, Galal, Mohamed, Nashwa H., Abdel-Daim, Mohamed M., Al Naggar, Yahya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Environmental Factors and the Epidemics of COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088405/
https://www.ncbi.nlm.nih.gov/pubmed/33934306
http://dx.doi.org/10.1007/s11356-021-14195-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088405/
https://www.ncbi.nlm.nih.gov/pubmed/33934306
http://dx.doi.org/10.1007/s11356-021-14195-9

Ejemplares similares